GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CardioComm Solutions Inc (TSXV:EKG) » Definitions » YoY Rev. per Sh. Growth

CardioComm Solutions (TSXV:EKG) YoY Rev. per Sh. Growth : -50.00% (As of Sep. 2024)


View and export this data going back to 1989. Start your Free Trial

What is CardioComm Solutions YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. CardioComm Solutions's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was -50.00%.

CardioComm Solutions's Revenue per Share for the three months ended in Sep. 2024 was C$0.00.


CardioComm Solutions YoY Rev. per Sh. Growth Historical Data

The historical data trend for CardioComm Solutions's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioComm Solutions YoY Rev. per Sh. Growth Chart

CardioComm Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.00 - -16.67 40.00 -14.29

CardioComm Solutions Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.00 -50.00 -50.00 - -50.00

CardioComm Solutions YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

CardioComm Solutions's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0.006-0.007)/ | 0.007 |
=-14.29 %

CardioComm Solutions's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(0.001-0.002)/ | 0.002 |
=-50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioComm Solutions YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of CardioComm Solutions's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioComm Solutions Business Description

Traded in Other Exchanges
Address
18 Wynford Drive, Suite 305, North York, ON, CAN, M3C 3S2
CardioComm Solutions Inc develops advanced software, hardware and core laboratory reading services related to the electrocardiogram ("ECG") and ambulatory arrhythmia monitoring systems for medical and consumer markets. It engages in the provision of management software solutions. It specializes in software engineering of computer-based electrocardiogram management and reporting software. The company's products include software, Gems Win, Global ECG Management System, GlobalCardio 12 lead; hardware, include handheld ECG monitor; Asp Services, include ECG management service and smart monitoring; software modules, consists of Win Air, Auto attendant, HL7 interface and EMR integration; and other products, include ECG viewer SDK and QRS 12 lead universal.
Executives
Etienne Anthony Grima Director
Steven Vincent Benyo Director

CardioComm Solutions Headlines